Prolonged oral versus high-dose intravenous etoposide in combination with carboplatin for stage IV non-small-cell lung cancer (NSCLC): a randomized trial-Reference-Cited by-同舟云学术

Prolonged oral versus high-dose intravenous etoposide in combination with carboplatin for stage IV non-small-cell lung cancer (NSCLC): a randomized trial

Published:1999-09 Issue:3 Volume:25 Page:207-214
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Jeremic Branislav,Shibamoto Yuta,Milicic Biljana,Milisavljevic Slobodan,Nikolic Nebojsa,Dagovic Aleksandar,Aleksandrovic Jasna,Radosavljevic-Asic Gordana

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference48 articles.

1. Chemotherapy of lung cancer;Ihde;New Engl J Med,1992

2. Chemotherapy for unresectable non-small cell lung cancer;Johnson;Semin Oncol,1990

3. Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group study;Finkelstein;J Clin Oncol,1986

4. Survival determinants in extensive stage non-small cell lung cancer: the Southwest Oncology Group experience;Albain;J Clin Oncol,1991

5. Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP-16-213 (NSC-141540) in L1210 leukemia;Dombernowsky;Acta Pathol Microb Scand (A),1973

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent or Sequential Chemoradiotherapy after 3-4 Cycles Induction Chemotherapy for LS-SCLC with Bulky Tumor;Journal of Cancer;2020

2. Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3);Medical Oncology;2018-03-06

3. Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumors;Anti-Cancer Drugs;2010-11

4. Chemotherapy dose–response relationships in non-small cell lung cancer and implied resistance mechanisms;Cancer Treatment Reviews;2007-04

5. Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy;Journal of Cancer Research and Clinical Oncology;2003-02